Specifically, the impact of RBP4 on various pathways associated with physiological processes such as adipogenesis and gluconeogenesis, as well as disease-promoting activities like impairing insulin signaling and causing insulin resistance during the development of diabetes, make this lipocalin an intriguing therapeutic target for combating metabolic diseases (Figure 4). Here, RBP4 is linked to Insulin resistance.